James Cardelli
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$4.5MFederal grants as PI10 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
10 awards · $4.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 22, 2026 | NIH | STTR Phase I Repurposing Pyrvinium as an Inhalation Therapy for Idiopathic Pulmonary Fibrosis | $7K | Oleolive, Inc. |
| Sep 17, 2025 | NIH | STTR Phase I Repurposing Pyrvinium as an Inhalation Therapy for Idiopathic Pulmonary Fibrosis | $309K | Oleolive, Inc. |
| Sep 20, 2023 | NIH | STTR Phase II Evaluation of a dual PPAR agonist for treatment of Alzheimer's disease | $250K | Oleolive, Inc. |
| May 4, 2023 | NIH | STTR Phase II Evaluation of a dual PPAR agonist for treatment of Alzheimer's disease | $806K | Oleolive, Inc. |
| Sep 9, 2022 | NIH | STTR Phase II Evaluation of a dual PPAR agonist for treatment of Alzheimer's disease | $1.7M | Oleolive, Inc. |
| May 20, 2020 | NIH | SBIR Phase I Evaluation of a selective PPAR-gamma agonist for treatment of Alzheimer’s Disease | $103K | Oleolive, Inc. |
| May 1, 2020 | DoD | SBIR Phase II Open Call for Innovative Defense-Related Dual-Purpose Technologies/Solutions with a Clear Air Force Stakeholder Need | $500K | Oleolive, Inc. |
| Sep 1, 2019 | NIH | SBIR Phase I Evaluation of a selective PPAR-gamma agonist for treatment of Alzheimer’s Disease | $450K | Oleolive, Inc. |
| May 27, 2019 | NIH | SBIR Phase I Evaluation of oral oleocanthal to prevent and/or treat Alzheimer’s disease and related dementias | $67K | Oleolive, Inc. |
| Sep 18, 2018 | NIH | SBIR Phase I Evaluation of oral oleocanthal to prevent and/or treat Alzheimer’s disease and related dementias | $270K | Oleolive, Inc. |
Peer ranks
Federal funding#332
Awards as PI#128
Patents#273
Companies
- Oleolive, Inc.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.